ArticleInvestigational new drugs2020
A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study.
Sarah Lapointe et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled itcites it